{"id":"W2163760444","doi":"10.1093/annonc/mdt375","title":"Overall survival for sorafenib plus interleukin-2 compared with sorafenib alone in metastatic renal cell carcinoma (mRCC): final results of the ROSORC trial","year":2013,"lang":"en","type":"article","venue":"Annals of Oncology","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":false,"ca_institutions":"University Hospital Foundation","funders":"Bayer HealthCare","keywords":"Sorafenib; Medicine; Renal cell carcinoma; Interquartile range; Internal medicine; Confidence interval; Oncology; Refractory (planetary science); Urology; Surgery; Gastroenterology; Hepatocellular carcinoma","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002047618,0.001555995,0.00272838,0.0002366723,0.0002934738,0.001142245,0.000764701,0.0008601541,0.002365039],"category_scores_gemma":[0.00174764,0.0003135611,0.003644658,0.0003139715,0.0007408558,0.001041861,0.0005134558,0.00311378,0.0004754066],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001046317,"about_ca_system_score_gemma":0.0008529157,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001706337,"about_ca_topic_score_gemma":0.004189561,"domain_scores_codex":[0.9991521,0.0004672289,0.00004438143,0.0001342479,0.00005826423,0.0001438252],"domain_scores_gemma":[0.9991183,0.0002745819,0.0002168001,0.00008396425,0.00005161691,0.0002548132],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.958798,0.001611939,0.003130564,0.0008301669,0.004691238,0.0000778117,0.00007532576,0.002026556,0.002446316,0.0001707779,0.00183379,0.02430754],"study_design_scores_gemma":[0.7797416,0.1695102,0.0303376,0.0001862059,0.01129849,0.0002498819,0.0001835682,0.002883905,0.002065079,0.0009242918,0.002530323,0.000088844],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9918548,0.005048593,0.0002104507,0.0005897272,0.0002647085,0.0001430109,0.0006846479,0.00004698702,0.001157128],"genre_scores_gemma":[0.9953526,0.001569795,0.0002773485,0.0003147107,0.0002324004,0.0001474626,0.0008940923,0.00001625535,0.001195171],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.00272838,"threshold_uncertainty_score":0.01082897,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1524323929279741,"score_gpt":0.3534303327248104,"score_spread":0.2009979397968364,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}